Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade.
Huang, Shyh-Min
Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. [electronic resource] - Molecular cancer therapeutics May 2002 - 507-14 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1535-7163
Animals
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Carcinoma, Squamous Cell--metabolism
Cell Movement
Cells, Cultured
Cetuximab
Chemotaxis
Collagen--pharmacology
Dose-Response Relationship, Drug
Down-Regulation
Drug Combinations
Endothelium, Vascular--cytology
Epidermal Growth Factor--metabolism
Extracellular Matrix--metabolism
Fibronectins--metabolism
Head and Neck Neoplasms--metabolism
Humans
Immunohistochemistry
Laminin--pharmacology
Matrix Metalloproteinase 9--metabolism
Mice
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasm Transplantation
Neovascularization, Pathologic
Proteoglycans--pharmacology
Time Factors
Tumor Cells, Cultured
Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. [electronic resource] - Molecular cancer therapeutics May 2002 - 507-14 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1535-7163
Animals
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Carcinoma, Squamous Cell--metabolism
Cell Movement
Cells, Cultured
Cetuximab
Chemotaxis
Collagen--pharmacology
Dose-Response Relationship, Drug
Down-Regulation
Drug Combinations
Endothelium, Vascular--cytology
Epidermal Growth Factor--metabolism
Extracellular Matrix--metabolism
Fibronectins--metabolism
Head and Neck Neoplasms--metabolism
Humans
Immunohistochemistry
Laminin--pharmacology
Matrix Metalloproteinase 9--metabolism
Mice
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasm Transplantation
Neovascularization, Pathologic
Proteoglycans--pharmacology
Time Factors
Tumor Cells, Cultured